Shine-On BioMedical Co.,Ltd. Stock

Equities

6926

TW0006926009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 18:00:00 2024-05-30 EDT 5-day change 1st Jan Change
64.9 TWD -1.67% Intraday chart for Shine-On BioMedical Co.,Ltd. -0.46% -6.48%

Financials

Sales 2022 - Sales 2023 9.52 308.96 13 Capitalization 3.46B 112B 4.72B
Net income 2022 -19M -616M -25.94M Net income 2023 -37M -1.2B -50.52M EV / Sales 2022 -
Net cash position 2022 1.16B 37.78B 1.59B Net cash position 2023 1.14B 36.87B 1.55B EV / Sales 2023 243,556,699 x
P/E ratio 2022
-147 x
P/E ratio 2023
-92.5 x
Employees 19
Yield 2022 *
-
Yield 2023
-
Free-Float 81.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.67%
1 week-0.46%
1 month-0.76%
3 months-1.67%
6 months+2.04%
Current year-6.48%
More quotes
1 week
64.00
Extreme 64
66.20
1 month
63.00
Extreme 63
66.20
Current year
61.10
Extreme 61.1
68.20
1 year
58.50
Extreme 58.5
80.00
3 years
45.00
Extreme 45
93.00
5 years
45.00
Extreme 45
93.00
10 years
45.00
Extreme 45
93.00
More quotes
Date Price Change Volume
24-05-31 64.9 -1.67% 14,000
24-05-30 66 +1.54% 3,000
24-05-29 65 -1.81% 8,000
24-05-28 66.2 +1.85% 1,000
24-05-27 65 -0.31% 13,000

End-of-day quote Taipei Exchange, May 30, 2024

More quotes
Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody engaging immune cells (SOA201), iNb Intrabody nanoscale intracellular specific antibody drug (SOA102), iNb STAR TriTE T cell receptor Nano-scale trispecific antibody drug (SOA103). Nucleic acid drugs include exosome-carrying nucleic acid and chemotherapy drugs (SOB101).
More about the company